West Pharma
West Pharmaceutical Services has announced the commercial introduction of its ID adapter. West acquired a license to the technology in 2010 and has completed the product development and first phase of commercial scale-up at its manufacturing centre in Arizona. West recently received 510K clearance for the ID adapter from the FDA.
The adapter is designed to help improve the consistency and reliability of intradermal injections for vaccines and other injectable drugs. The system will complement West’s portfolio of prefilled syringe offerings and technologies. Correctly administered intradermal injections can help conserve the supply of high-value vaccines and can significantly benefit patients through more reliable injection. The ID Adapter will provide an alternative to the Mantoux method, the industry standard for intradermal injection since 1907. The Mantoux method is accomplished by inserting the needle into the skin at a very shallow angle. It requires extensive training and experience to perform correctly and consistently, whereas the ID adapter enables this process to be carried out more easily and with greater reliability.
“We are delighted to offer our customers a solution which can improve reliability and performance of intradermal injections and meet growing market demands in this area,” said John Paproski, President, Pharmaceutical Delivery Systems, West.
West Pharmaceutical Services, Inc., +1 610 594 2900, west.pharmaceutical.services@westpharma.com, www.westpharma.com.